NYSE : RCUS

Arcus Biosciences, Inc.

$28.02 USD

-$0.31 (-1.09%)

Volume
565.74K
Average Volume
1.32M
Market Capitalization
$2.82B
P/E Ratio
-8.85
Dividend Yield
0.00%
Price Target
$29.00
Year High
$31.74
Year Low
$8.84
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$4.04

RCUS Estimated and Actual Revenue by Quarter

RCUS Estimated and Actual EPS by Quarter

RCUS Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2029-12-31 3 -178.1M -108.95M -143.84M -178.58M -109.25M -144.23M
2029-09-30 3 -155.03M -94.84M -125.21M -155.45M -95.1M -125.55M
2029-06-30 3 -132.42M -81.01M -106.95M -132.78M -81.23M -107.24M
2029-03-31 5 -112.35M -68.73M -90.74M -112.65M -68.92M -90.98M
2028-12-31 4 -97.63M -59.73M -78.85M -97.9M -59.89M -79.07M
2028-09-30 4 -56.19M -34.37M -45.38M -56.34M -34.47M -45.5M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2029-12-31 3 -41.93M -21.92M -32.01M 85.75M 140.17M 113.21M
2029-09-30 3 -58.32M -30.49M -44.53M 74.65M 122.02M 98.55M
2029-06-30 3 -71.42M -37.34M -54.54M 63.76M 104.23M 84.18M
2029-03-31 5 -83.25M -43.52M -63.57M 54.1M 88.42M 71.42M
2028-12-31 4 -91.38M -47.77M -69.77M 47.01M 76.84M 62.06M
2028-09-30 4 -118.24M -61.82M -90.29M 27.05M 44.22M 35.72M
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2029-12-31 3 141.65M 231.54M 187M 1 -0.33434 -0.17481 -0.2553
2029-09-30 3 123.3M 201.55M 162.78M 1 -0.46504 -0.24314 -0.3551
2029-06-30 3 105.32M 172.16M 139.04M 1 -0.56955 -0.29778 -0.4349
2029-03-31 5 89.35M 146.06M 117.96M 1 -0.66384 -0.34708 -0.5069
2028-12-31 4 77.65M 126.93M 102.51M 2 -0.72867 -0.38097 -0.5564
2028-09-30 4 44.69M 73.04M 58.99M 2 -0.94292 -0.49299 -0.72